T Lymphocytes Cash Their Value in Clinical Medicine

Tsokos, G. C., & Terhorst, C. (2020). T Lymphocytes Cash Their Value in Clinical Medicine. Trends Mol Med, 26, 800-802.

Abstract

Empowering the ability of cytotoxic T cells to kill tumor cells or the reframing of their receptor to eliminate cancer cells has revolutionized cancer treatment. Simultaneously, the empowering of regulatory subsets has met success in mitigating autoimmune diseases. T cells, the major first responders of the immune system, are produced in the thymus, an organ that serves as their 'training camp'. On their exit to the periphery, T cells are effector cells that control infections or regulatory cells, which limit excessive responses.
Last updated on 02/17/2024